Academic Journal

Effect of Procaterol, a β2 Selective Adrenergic Receptor Agonist, on Airway Inflammation and Hyperresponsiveness

التفاصيل البيبلوغرافية
العنوان: Effect of Procaterol, a β2 Selective Adrenergic Receptor Agonist, on Airway Inflammation and Hyperresponsiveness
المؤلفون: Hiroyuki Tashimo, Naomi Yamashita, Hirofumi Ishida, Hiroyuki Nagase, Tetsuya Adachi, Junichi Nakano, Koichi Yamamura, Tomoko Yano, Hisanao Yoshihara, Ken Ohta
المصدر: Allergology International, Vol 56, Iss 3, Pp 241-247 (2007)
بيانات النشر: Elsevier, 2007.
سنة النشر: 2007
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: airway hyperresponsiveness, allergic inflammation, eosinophil, murine model, β2 adrenergic receptor agonist, Immunologic diseases. Allergy, RC581-607
الوصف: Background: β-agonists are frequently used as bronchodilators for asthma as not only a reliever but also a controller, and their utility has increased with the development of long-acting β2 selective drugs. Although antiinflammatory effects of β2 selective-agonists have been reported in vitro, side effects on augmentation of airway hyperresponsiveness by chronic use of β2 selective-agonists have been described in several reports. In this study, we investigated the effects of procaterol, a second-generation β2-agonist, on airway inflammation in vivo using an antigen-specific murine model of asthma. Methods: Mice immunized with ovalbumin (OVA) + alum and challenged with inhaled ovalbumin were orally administered procaterol during the challenge. After inhalation, the mice were tracheostomized and placed in a body box under controlled ventilation to measure airway resistance before and after acetylcholine inhalation. Results: Administration of procaterol at a clinical dose equivalent did not augment airway hyperresponsiveness, inflammation of the airway wall, or subsequent airway wall thickening induced by OVA inhalation. BALF cell analysis revealed that the eosinophil number in the BALF was significantly reduced in procaterol-treated mice compared to untreated mice. Conclusions: Oral administration of procaterol at a clinical dose did not augment airway responsiveness, but did reduce eosinophil inflammation.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1323-8930
Relation: http://www.sciencedirect.com/science/article/pii/S1323893015308716; https://doaj.org/toc/1323-8930
DOI: 10.2332/allergolint.O-06-456
URL الوصول: https://doaj.org/article/fce6221c452c4ca7b78ee8bb40300829
رقم الانضمام: edsdoj.fce6221c452c4ca7b78ee8bb40300829
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:13238930
DOI:10.2332/allergolint.O-06-456